| Bioactivity | Polθ-IN-1-d3 (example 1) is a deuterated Polθ inhibitor used for cancer study (extracted from patent WO2021028670)[1]. |
| Name | Polθ-IN-1-d3 |
| CAS | 2598122-35-9 |
| Formula | C19H12D3ClF5N3O4 |
| Molar Mass | 482.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER. Patent WO2021028670. |
Polθ-IN-1-d3
CAS: 2598122-35-9 F: C19H12D3ClF5N3O4 W: 482.80
Polθ-IN-1-d3 (example 1) is a deuterated Polθ inhibitor used for cancer study (extracted from patent WO2021028670).
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.